In Highly Pretreated KMT2A-Rearranged Leukemia, Novel Targeted Therapy Achieves MRD Negativity

In highly pretreated histone lysine N-methyltransferase 2A (KMT2A)-rearranged acute leukemia, a small molecule ...

FEBRUARY 9, 2024